Form4insider filings, from the source

Insider holders · CIK 0001583771

Hepion Pharmaceuticals, Inc. · HEPA

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Vincent S LoPrioreExecutive Chairman—16,250,00016,250,000Aug 12, 2026 · 9:34 pm EDTForm 4
KI Holdings, Ltd.10% Owner—10,000,00010,000,000Sep 16, 2026 · 4:18 pm EDTForm 3
Black Global 5 LLC10% Owner—10,000,00010,000,000Aug 7, 2026 · 5:05 pm EDTForm 3
Gabriel Cerrone10% Owner78,1465,105,4335,183,579Aug 17, 2016 · 5:07 pm EDTForm 3
Sireesh AppajosyulaChief Operating Officer3,250,000—3,250,000Aug 12, 2026 · 9:36 pm EDTForm 4
Michael J. PurcellDirector3,250,000—3,250,000Aug 12, 2026 · 9:39 pm EDTForm 4
Gary S. StetzInterim CEO3,250,000—3,250,000Aug 12, 2026 · 9:41 pm EDTForm 4
Gary S. Stetz IIDirector500,000—500,000Aug 12, 2026 · 9:43 pm EDTForm 4
James SapirsteinChief Executive Officer492,819—492,819Jan 5, 2018 · 1:09 pm ESTForm 4
John T CavanCFO167,947—167,947Jan 5, 2018 · 1:09 pm ESTForm 4
Robert T FosterChief Scientific Officer144,736—144,736Jan 5, 2018 · 1:08 pm ESTForm 4
John Z Sullivan-BolyaiChief Medical Officer58,681—58,681Jul 7, 2017 · 5:00 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.